3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 1
4
Phase EARLY_PHASE1
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Melanoma
11
Neoplasm Metastasis
8
Prostatic Neoplasms
6
Triple Negative Breast Neoplasms
5
Multiple Myeloma
5
Lymphoma, Mantle-Cell
5
Lymphoma
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
4
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Fallopian Tube Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Liposarcoma
2
Glioma
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Renal Cell
2
Interventions
pembrolizumab
16
Carboplatin
10
Paclitaxel
8
Nivolumab
7
Bevacizumab
6
Gemcitabine
4
Fulvestrant
4
Cisplatin
4
olaparib
3
lenvatinib
3
abemaciclib
3
PM 01183
3
Oxaliplatin
3
Leucovorin
3
Letrozole
3
Docetaxel
3
AZD5305
3
tisotumab vedotin
2
spartalizumab
2
sarilumab
2
sargramostim
2
sacituzumab govitecan
2
ribociclib
2
palbociclib
2
epacadostat
2
enzalutamide
2
dostarlimab
2
cemiplimab
2
anlotinib
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Endometrial Neoplasms
×
Biopsy
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled